a developer of biologic drugs, novel oncology therapeutics, and vaccinations
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ICVPX | 17.00 | 0.26 | +1.55% |
VY® Columbia Small Cap Value II S2 | |||
DNLCX | 57.36 | 0.85 | +1.50% |
BNY Mellon Active MidCap C | |||
FASDX | 17.92 | 0.15 | +0.84% |
Fidelity Advisor Strategic Div & Inc A | |||
GLCTX | 33.13 | N/A | N/A |
Goldman Sachs Large Cap Gr Insghts Inv | |||
UUPSX | 44.98 | -0.40 | -0.88% |
ProFunds UltraEmerging Markets Svc |
A.I.dvisor indicates that over the last year, XBIO has been loosely correlated with SYRE. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if XBIO jumps, then SYRE could also see price increases.
Ticker / NAME | Correlation To XBIO | 1D Price Change % | ||
---|---|---|---|---|
XBIO | 100% | +0.57% | ||
SYRE - XBIO | 34% Loosely correlated | -1.82% | ||
VXRT - XBIO | 29% Poorly correlated | -1.40% | ||
EDSA - XBIO | 29% Poorly correlated | -4.09% | ||
CDTX - XBIO | 28% Poorly correlated | +15.41% | ||
AUTL - XBIO | 27% Poorly correlated | +1.43% | ||
More |